Peer Review reports
From: Ttc39c is a potential target for the treatment of lung cancer
| Original Submission | ||
|---|---|---|
| 8 Jul 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 31 Jul 2022 | Reviewed | Reviewer Report |
| 1 Aug 2022 | Reviewed | Reviewer Report - Liangyuan Chen |
| 13 Aug 2022 | Author responded | Author comments - Jin-Tao He |
| Resubmission - Version 3 | ||
| 13 Aug 2022 | Submitted | Manuscript version 3 |
| 15 Aug 2022 | Author responded | Author comments - Jin-Tao He |
| Resubmission - Version 4 | ||
| 15 Aug 2022 | Submitted | Manuscript version 4 |
| 18 Aug 2022 | Author responded | Author comments - Jin-Tao He |
| Resubmission - Version 5 | ||
| 18 Aug 2022 | Submitted | Manuscript version 5 |
| 9 Sep 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 19 Sep 2022 | Editorially accepted | |
| 27 Oct 2022 | Article published | 10.1186/s12890-022-02173-x |
You can find further information about peer review here.